HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akito Nozaki Selected Research

Radiofrequency Ablation

1/2022Combination Therapy With Lenvatinib and Radiofrequency Ablation for Patients With Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh Class A Liver function: A Pilot Study.
1/2020Intraprocedurally EOB-MRI/US fusion imaging focusing on hepatobiliary phase findings can help to reduce the recurrence of hepatocellular carcinoma after radiofrequency ablation.
1/2018A new device for fiducial registration of image-guided navigation system for liver RFA.
8/2014Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysis.
10/2012Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
3/2012Findings of multidetector row computed tomography of HCCs treated by HIFU ablation.
12/2010Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization.
5/2010C-arm cone beam CT for hepatic tumor ablation under real-time 3D imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akito Nozaki Research Topics

Disease

40Hepatocellular Carcinoma (Hepatoma)
03/2024 - 06/2002
15Neoplasms (Cancer)
01/2022 - 01/2009
13Infections
07/2023 - 04/2002
12Fibrosis (Cirrhosis)
05/2024 - 09/2013
10Chronic Hepatitis C
01/2022 - 04/2002
5Chronic Hepatitis B
04/2024 - 12/2013
4Liver Cirrhosis (Hepatic Cirrhosis)
05/2024 - 01/2021
3Thrombosis (Thrombus)
01/2023 - 01/2011
3Liver Diseases (Liver Disease)
01/2021 - 10/2015
3Neoplasm Metastasis (Metastasis)
01/2020 - 05/2010
2Hepatitis B
04/2024 - 09/2023
2Liver Neoplasms (Liver Cancer)
10/2023 - 02/2012
2Hepatitis C
10/2023 - 04/2002
2Hepatic Encephalopathy
01/2021 - 12/2013
2Rheumatoid Arthritis
10/2016 - 06/2012
2Necrosis
08/2015 - 08/2014
2Hepatitis
10/2013 - 06/2012
2Chronic Hepatitis (Chronic Active Hepatitis)
10/2004 - 04/2002
1Esophageal and Gastric Varices (Esophageal Varices)
05/2024
1Fatty Liver
10/2023
1Hypertension (High Blood Pressure)
10/2023
1Overweight
09/2023
1Dyspnea (Shortness of Breath)
02/2023
1End Stage Liver Disease
01/2023
1Carcinogenesis
01/2023
1Communicable Diseases (Infectious Diseases)
09/2022
1Ascites
01/2021
1Pleural Effusion (Pleural Effusions)
01/2021
1Edema (Dropsy)
07/2020
1Virus Diseases (Viral Diseases)
05/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2016
1Autoimmune Diseases (Autoimmune Disease)
10/2016
1Stomach Neoplasms (Stomach Cancer)
06/2014
1Leukemia
06/2014

Drug/Important Bio-Agent (IBA)

17Antiviral Agents (Antivirals)IBA
05/2024 - 04/2002
8Contrast MediaIBA
10/2015 - 01/2009
8perfluorobutane (AI 700)IBA
10/2015 - 01/2009
6Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2002
6Sorafenib (BAY 43-9006)FDA Link
01/2022 - 02/2012
4lenvatinibIBA
08/2022 - 01/2020
4SofosbuvirIBA
03/2022 - 12/2020
4SonazoidIBA
06/2021 - 04/2009
4Pentetic Acid (DTPA)FDA LinkGeneric
06/2021 - 03/2013
4GadoliniumIBA
06/2021 - 03/2013
4InterferonsIBA
05/2019 - 04/2002
3Alanine Transaminase (SGPT)IBA
04/2024 - 09/2023
3entecavirFDA Link
03/2024 - 01/2021
3Ribavirin (Virazole)FDA LinkGeneric
10/2023 - 09/2013
3velpatasvirIBA
03/2022 - 12/2020
3glecaprevir and pibrentasvirIBA
05/2020 - 01/2019
3Biomarkers (Surrogate Marker)IBA
01/2020 - 08/2012
2NucleosidesIBA
04/2024 - 10/2023
2Tenofovir (Viread)FDA Link
03/2024 - 09/2023
2AlbuminsIBA
10/2023 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
09/2023 - 01/2020
2acarboxyprothrombin (PIVKA)IBA
11/2020 - 01/2017
2glecaprevirIBA
08/2020 - 05/2020
2pibrentasvirIBA
08/2020 - 05/2020
2Methotrexate (Mexate)FDA LinkGeneric
10/2016 - 06/2012
2Cisplatin (Platino)FDA LinkGeneric
03/2015 - 01/2011
2Indicators and Reagents (Reagents)IBA
04/2010 - 04/2002
2Amino AcidsFDA Link
01/2007 - 03/2003
2LactoferrinIBA
01/2007 - 04/2002
1tenofovir alafenamideIBA
04/2024
1AntigensIBA
04/2024
1TransferasesIBA
10/2023
1NucleotidesIBA
10/2023
1Protease Inhibitors (Protease Inhibitor)IBA
10/2023
1Hemoglobins (Hemoglobin)IBA
10/2023
1Cytidine Triphosphate (CTP)IBA
10/2023
1Brain Natriuretic Peptide (Natrecor)FDA Link
02/2023
1SodiumIBA
01/2023
1Hepatitis C AntibodiesIBA
09/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2022
1Polysaccharides (Glycans)IBA
01/2022
1EnzymesIBA
01/2022
1sofosbuvir drug combination ledipasvirIBA
03/2021
1AmmoniaIBA
01/2021
1Collagen Type IV (Type IV Collagen)IBA
01/2021
1Hyaluronic Acid (Hyaluronan)IBA
01/2021
1Tumor Biomarkers (Tumor Markers)IBA
11/2020
1DiureticsIBA
07/2020
1Furosemide (Lasix)FDA LinkGeneric
07/2020
1TolvaptanFDA Link
07/2020
1Spironolactone (Aldactone)FDA LinkGeneric
07/2020
1SimeprevirIBA
06/2020
1odalasvirIBA
06/2020
1adafosbuvirIBA
06/2020
1Circulating Tumor DNAIBA
01/2020
1MicroRNAs (MicroRNA)IBA
07/2019
1N 30IBA
08/2014

Therapy/Procedure

19Therapeutics
09/2023 - 04/2002
8Radiofrequency Ablation
01/2022 - 05/2010
3High-Intensity Focused Ultrasound Ablation
12/2013 - 08/2010
2Drug Therapy (Chemotherapy)
01/2020 - 03/2015
2Punctures
01/2018 - 08/2014
1Thrombolytic Therapy
01/2023
1Duration of Therapy
08/2020
1Microspheres (Microsphere)
08/2015